160 related articles for article (PubMed ID: 15196540)
1. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent.
Gong YQ; Fan Y; Wu DZ; Yang H; Hu ZB; Wang ZT
Eur J Cancer; 2004 Jul; 40(10):1554-65. PubMed ID: 15196540
[TBL] [Abstract][Full Text] [Related]
2. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
[TBL] [Abstract][Full Text] [Related]
5. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic function of tocotrienol.
Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
8. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
9. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
10. Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis.
Su C; Zhang P; Liu J; Cao Y
Biomed Pharmacother; 2017 Apr; 88():521-528. PubMed ID: 28129624
[TBL] [Abstract][Full Text] [Related]
11. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
12. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis.
Lee JH; Lee DH; Lee HS; Choi JS; Kim KW; Hong SS
Oncol Rep; 2008 Jul; 20(1):129-34. PubMed ID: 18575727
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
[TBL] [Abstract][Full Text] [Related]
14. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
[TBL] [Abstract][Full Text] [Related]
16. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
Kruczynski A; Poli M; Dossi R; Chazottes E; Berrichon G; Ricome C; Giavazzi R; Hill BT; Taraboletti G
Eur J Cancer; 2006 Nov; 42(16):2821-32. PubMed ID: 16973349
[TBL] [Abstract][Full Text] [Related]
18. Erianin induces a JNK/SAPK-dependent metabolic inhibition in human umbilical vein endothelial cells.
Gong Y; Fan Y; Liu L; Wu D; Chang Z; Wang Z
In Vivo; 2004; 18(2):223-8. PubMed ID: 15113050
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
[TBL] [Abstract][Full Text] [Related]
20. Natural antioxidant pedicularioside G inhibits angiogenesis and tumourigenesis in vitro and in vivo.
Mu P; Gao X; Jia ZJ; Zheng RL
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):30-4. PubMed ID: 17973903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
